Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Shandong Luye Pharmaceutical
Shandong Luye Pharmaceutical
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Rykindo
Risperidone
2023-01-13
2025-2033
Dementia
,
Tourette syndrome
,
Schizophrenia
,
Bipolar disorder
,
Autistic disorder
,
Schizophrenia spectrum and other psychotic disorders
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Toludesvenlafaxine
hepatic insufficiency
,
type 2 diabetes mellitus
,
prediabetic state
,
insulin resistance
,
glucose intolerance
,
fibromyalgia
,
healthy volunteers/patients
,
pain
,
diabetic neuropathies
,
diabetes mellitus
,
peripheral nervous system diseases
,
sleep initiation and maintenance disorders
,
cardiovascular diseases
,
neoplasms
,
postpartum depression
,
myofascial pain syndromes
,
menopause
,
major depressive disorder
,
depressive disorder
,
depression
,
hot flashes
,
dysthymic disorder
,
anxiety disorders
,
pharmacokinetics
,
anhedonia
,
generalized anxiety disorder
,
breast neoplasms
,
opioid-related disorders
,
vascular depression
,
social phobia
,
neuroticism
,
medically unexplained symptoms
,
bipolar disorder
,
cancer pain
,
vomiting
,
nausea
,
adjustment disorders
Glycididazole
chemoradiotherapy
,
esophageal neoplasms
,
carcinoma
,
squamous cell carcinoma
Taxane
vomiting
,
nausea
,
prostatic neoplasms
,
male breast neoplasms
,
endometrial neoplasms
,
urinary bladder neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
carcinoma
,
renal cell carcinoma
,
cutaneous malignant melanoma
,
uterine diseases
,
uterine cervical diseases
,
endometrioid carcinoma
,
fallopian tube neoplasms
,
head and neck neoplasms
,
squamous cell carcinoma
,
disease progression
,
mediastinal neoplasms
,
neoplasm metastasis
,
transitional cell carcinoma
,
uterine neoplasms
,
uterine cervical neoplasms
,
clear cell adenocarcinoma
,
large cell carcinoma
,
vaginal neoplasms
,
vulvar neoplasms
,
adenomyoepithelioma
,
breast neoplasms
,
neoplasms
,
ovarian neoplasms
,
non-small-cell lung carcinoma
,
ovarian epithelial carcinoma
,
inflammatory breast neoplasms
,
ductal carcinoma breast
,
recurrence
,
lung neoplasms
,
stomach neoplasms
,
gastrointestinal neoplasms
,
mucinous adenocarcinoma
,
cervical intraepithelial neoplasia
,
uterine cervical dysplasia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use